Frank G. A. Jansman

2.6k total citations
70 papers, 1.9k citations indexed

About

Frank G. A. Jansman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Frank G. A. Jansman has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Frank G. A. Jansman's work include Cancer Treatment and Pharmacology (15 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Frank G. A. Jansman is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Frank G. A. Jansman collaborates with scholars based in Netherlands, United States and United Kingdom. Frank G. A. Jansman's co-authors include Roelof W. F. van Leeuwen, Ron H.J. Mathijssen, Teun van Gelder, J. R. B. J. Brouwers, David M. Burger, Cees Neef, Maarten J. Postma, Nielka P. van Erp, Patricia M. L. A. van den Bemt and G. Veerman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Frank G. A. Jansman

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank G. A. Jansman Netherlands 25 668 416 334 316 270 70 1.9k
Roelof W. F. van Leeuwen Netherlands 16 508 0.8× 354 0.9× 239 0.7× 246 0.8× 163 0.6× 37 1.2k
Susan Goodin United States 30 1.3k 2.0× 625 1.5× 164 0.5× 1.2k 3.7× 230 0.9× 99 3.4k
R. Lassalle France 22 242 0.4× 404 1.0× 117 0.4× 260 0.8× 141 0.5× 98 2.4k
Sebastian Harder Germany 34 422 0.6× 214 0.5× 147 0.4× 402 1.3× 203 0.8× 109 3.5k
Mary T. Brophy United States 28 262 0.4× 436 1.0× 149 0.4× 285 0.9× 72 0.3× 114 3.3k
Benoı̂t Blanchet France 36 1.1k 1.7× 811 1.9× 145 0.4× 965 3.1× 203 0.8× 139 3.6k
Frieder Keller Germany 29 246 0.4× 418 1.0× 89 0.3× 333 1.1× 294 1.1× 160 2.8k
Stephen A. Bernard United States 28 823 1.2× 545 1.3× 135 0.4× 246 0.8× 409 1.5× 76 2.4k
Jung Mi Oh South Korea 24 204 0.3× 96 0.2× 139 0.4× 293 0.9× 379 1.4× 139 1.7k
Sigurd Vitols Sweden 28 368 0.6× 193 0.5× 82 0.2× 496 1.6× 618 2.3× 62 2.4k

Countries citing papers authored by Frank G. A. Jansman

Since Specialization
Citations

This map shows the geographic impact of Frank G. A. Jansman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank G. A. Jansman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank G. A. Jansman more than expected).

Fields of papers citing papers by Frank G. A. Jansman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank G. A. Jansman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank G. A. Jansman. The network helps show where Frank G. A. Jansman may publish in the future.

Co-authorship network of co-authors of Frank G. A. Jansman

This figure shows the co-authorship network connecting the top 25 collaborators of Frank G. A. Jansman. A scholar is included among the top collaborators of Frank G. A. Jansman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank G. A. Jansman. Frank G. A. Jansman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandon, Esther, et al.. (2024). A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions. Frontiers in Pharmacology. 15. 1412692–1412692. 2 indexed citations
2.
Heine, Rob ter, Michel M. van den Heuvel, Berber Piet, et al.. (2023). A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted Oncology. 18(3). 441–450. 8 indexed citations
3.
Vervenne, Walter L., Alexander L.T. Imholz, R.G.H.M. Cremers, et al.. (2023). Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer. Clinical Pharmacokinetics. 62(7). 989–996. 3 indexed citations
4.
Krens, Stefanie D., Frank G. A. Jansman, David M. Burger, et al.. (2021). The impact of a 1‐hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure. International Journal of Cancer. 148(11). 2799–2806. 12 indexed citations
5.
Kroes, Johannes A., Petra A.M.J. Scholtens, Claire Siemes, et al.. (2021). High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study. Supportive Care in Cancer. 30(1). 271–278. 14 indexed citations
6.
Riet, Esther van ‘t, et al.. (2020). Identifying patients with metformin associated lactic acidosis in the emergency department. International Journal of Clinical Pharmacy. 42(5). 1286–1292. 5 indexed citations
7.
Sluiter, Henk E., et al.. (2020). Pharmacist-led medication reviews in pre-dialysis and dialysis patients. Research in Social and Administrative Pharmacy. 16(12). 1718–1723. 7 indexed citations
8.
Krens, Stefanie D., Frank G. A. Jansman, Ingrid M.E. Desar, et al.. (2019). Dose recommendations for anticancer drugs in patients with renal or hepatic impairment. The Lancet Oncology. 20(4). e200–e207. 77 indexed citations
9.
Reuver, Philip R. de, André J. A. Bremers, Johannes H.W. de Wilt, et al.. (2018). Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure. British Journal of Clinical Pharmacology. 85(1). 47–58. 17 indexed citations
10.
Menezes, Gisela L. G., et al.. (2018). Burden of early, advanced and metastatic breast cancer in The Netherlands. BMC Cancer. 18(1). 262–262. 51 indexed citations
11.
Leeuwen, Roelof W. F. van, Frank G. A. Jansman, Nicole Hunfeld, et al.. (2017). Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options. Clinical Pharmacokinetics. 56(7). 683–688. 61 indexed citations
12.
Gelderblom, Hans, Frank G. A. Jansman, Angela Colbers, et al.. (2016). Food intervention to make therapy with pazopanib more patient-friendly and affordable.. Journal of Clinical Oncology. 34(15_suppl). 11040–11040. 3 indexed citations
13.
Rooijen, Johan M. van, Linda de Munck, Jacques C. de Graaf, et al.. (2015). Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice. Anti-Cancer Drugs. 27(2). 127–132. 6 indexed citations
14.
Jansman, Frank G. A., et al.. (2015). Rhabdomyolysis in Clozapine Overdose. PubMed. 2(1). 9–9. 6 indexed citations
15.
Leeuwen, Roelof W. F. van, Cees Neef, Teun van Gelder, et al.. (2013). Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs. British Journal of Cancer. 108(5). 1071–1078. 199 indexed citations
16.
Jansman, Frank G. A., et al.. (2011). Acute intoxication patients presenting to an emergency department in the Netherlands: admit or not? Prospective testing of two algorithms. Emergency Medicine Journal. 29(6). 467–472. 8 indexed citations
17.
Jansman, Frank G. A., et al.. (2007). Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharmacy World & Science. 30(1). 31–38. 70 indexed citations
18.
Jansman, Frank G. A., Maarten J. Postma, & J. R. B. J. Brouwers. (2007). Cost Considerations in the Treatment of Colorectal Cancer. PharmacoEconomics. 25(7). 537–562. 51 indexed citations
19.
Jansman, Frank G. A., Willem M. Smit, Jacques C. de Graaf, et al.. (2005). Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer. Clinical Therapeutics. 27(3). 327–335. 5 indexed citations
20.
Marel, Caroline D. van der, Brian J. Anderson, Richard A. van Lingen, et al.. (2003). Paracetamol and metabolite pharmacokinetics in infants. European Journal of Clinical Pharmacology. 59(3). 243–251. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roelof W. F. van Leeuwen Breakdown of academic impact, for papers by Susan Goodin Breakdown of academic impact, for papers by R. Lassalle Breakdown of academic impact, for papers by Sebastian Harder Breakdown of academic impact, for papers by Mary T. Brophy Breakdown of academic impact, for papers by Benoı̂t Blanchet Breakdown of academic impact, for papers by Frieder Keller Breakdown of academic impact, for papers by Stephen A. Bernard Breakdown of academic impact, for papers by Jung Mi Oh Breakdown of academic impact, for papers by Sigurd Vitols
Rankless by CCL
2026